Nicolas Graber

Career:Sep. 07-Dec 09: (2 years, 3 months)ZypAdhera launch leader Lilly European Operations. Responsible to support European affiliates for the launch of a new depot formulation of an atypical neuroleptic. • Conduct launch readiness ssessments • Close collaboration with global marketing team in Indianapolis on the marketing strategy and ensure European alignment to strategy • Responsible for the European role out of the global marketing campaign. • Involvement and driver of several global and European marketing projects. • Close collaboration with EU regulatory and manufacturing getting ready for launchFeb 04:Business Unit Manager Neuroscience Lilly Suisse S.A (3 years, 7 months)• Member of the Lilly Suisse Board (Geschäftsleitung) Heavy influence on all key decisions concerning the affiliate and close collaboration with other departments like Corporate Affairs and Medical to achieve affiliate goals.• Olanzapine sales plans were achieved in 2005 (37M CHF), SOM stabilized after significant loss the years before. Olanzapine turnaround major achievement.• Based on a heavy turnover in the past recreate, realign and remotivate the Neuroscience marketing and sales team (app. 25 team-members). BU turnaround and stabilization of employee loss major achievement• Close collaboration with two DSM in order to realign the sales force. Reintroducing sales fundamentals (joint call reports, message implementation). • In depth key opinion leader knowledge and strong field presence.January 02:Superviseur National des Ventes Psychiatrie, Lilly France (2 years)• Sales and management responsibility of 7 district sales managers and their regions (approximately 80 sales reps, 2/3 of the French territory). • Sales plan achieved• Very quickly adaptation to French working culture, achieved quickly the buy in of team. • DSM coaching on territory, sales fundamentals and people management. • Recreate together with the “sales operations” department sales fundamentals metrics (joint call reports, metric dashboard etc). • Member of the Zyprexa Schizophrenia brand team. Heavy influence on marketing strategySep 2000:National Sales Manager Psychiatry Lilly Suisse S.A (1 year, 4 months:• Sales and management responsibility of 9 sales representatives and 2 neurosciences specialists. • Responsible to implement the marketing strategy and the coaching of the sales team• Sales plan of the most important brands Zyprexa and Fluctine achieved 1999: Sales Manager German part of Switzerland Lilly Suisse S.A. • Sales and management responsibility of 12 sales representativesMay 1996Marketing Manager Zyprexa (schizophrenia) and Permax (Parkinson) Lilly Suisse S.A (2 years, 7 months)1995Manager Managed Care: Project Manager Disease Management program « Horizont » (depression) and Marketing Manager Calmaxid Lilly Suisse S.A 1993-1994Sales Representative central Switzerland Lilly Suisse S.AEducation1973-1978Primary school Allschwil (Primarschule)1978-1982Elementary school Allschwil (Progymnasium)1982-1987Holbeingymnasium Basel; certificate (matura) of languages1987-1992College University of Basel. Studies of economics with a master degree (Lizentiat lic.rer.pol)Languages:German, French, English, Spanish(fluent oral)German, French, English(written)Personal:Swiss citizen, born 13th June 1966, married since 1998 (spouce Spanish citizen) two sons: Joan (1999), Alex (2002). Passionate tennis player since more than 20 years, played twice tennis Swiss championship (2006/2007) (+35), current classification R4.References upon request